Myovant Sciences Ltd. MYOV
Quote time unavailable
Day range unavailable
52-week range unavailable
Fundamental scorecard
3 of 25 checks passed on MYOV’s reported financials
3of 25 checks passed
- Value 0 of 5
- Growth 2 of 5
- Profitability 0 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Dec 31, 2022.
Value 0 of 5
- Failed:P/E below its own 5-year median No profit over the last 12 months, so no P/E.
- Failed:P/E under 20 No profit over the last 12 months, so no P/E.
- No data:Price to sales below its own 5-year median Price to sales 6.9. Not enough data to decide.
- Failed:Price to book below its own 5-year median Shareholders’ equity is negative.
- Failed:Free cash flow yield above 4% Free cash flow of -271M is -10.3% of the market value.
Growth 2 of 5
- Passed:Revenue grew over the last year Revenue of 379M is +91.5% on the 12 months before.
- No data:Revenue grew more than 5% a year over five years Not enough data to decide.
- Passed:Earnings per share grew over the last year EPS -1.91 against -2.47 in the 12 months before.
- Failed:Earnings per share grew more than 5% a year over five years EPS -1.70 in FY 2017, -2.22 in FY 2022.
- No data:Analysts expect higher earnings per share over the next year No analyst estimate.
Profitability 0 of 5
- Failed:Profitable over the last year Net income of -184M over the last 12 months.
- Failed:Profitable in each of the last five fiscal years A profit in 0 of the last 5 fiscal years.
- Failed:Return on equity above 15% Shareholders’ equity is negative.
- No data:Net margin above its 5-year average Not enough data to decide.
- Failed:Free cash flow is at least 80% of net income No profit over the last 12 months to compare with.
Financial health 1 of 5
- Passed:Short-term assets cover short-term liabilities Short-term assets of 387M against short-term liabilities of 246M.
- Failed:Short-term assets cover long-term liabilities Short-term assets of 387M against long-term liabilities of 716M.
- Failed:Net debt under 40% of equity Shareholders’ equity is negative.
- Failed:Operating cash flow covers at least 20% of debt Operating cash flow of -270M is -73.6% of debt.
- Failed:Operating profit covers interest at least 3 times Operating profit is -7.7 times the interest expense.
Dividend 0 of 5
- Failed:Pays a dividend No dividend paid.
- Failed:Yield above 1.5% No dividend paid.
- Failed:Pays out under 75% of profit No dividend paid.
- Failed:Covered by free cash flow No dividend paid.
- Failed:Not cut in the last five fiscal years No dividend paid.
Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Financial position
What MYOV owns and owes, as of Dec 31, 2022
Short term and long term
Balance sheet · 404M of assets
Liabilities exceed assets, so there is no shareholders’ equity to show.
Debt, equity and cash by year
Now: 66.3M more cash than debt
- Equity
- Debt
- Cash
Fiscal years. Cash includes short-term investments.
From the company’s SEC filings.
Cash flow and returns
How MYOV’s profit turns into cash, and what its capital earns
From profit to free cash flow · Last 12 months
Returns on capital · Last 12 months
-
-36.5%
Return on assets
Below the 5% mark · Profit per dollar of everything it owns
-
-91.1%
Return on capital employed
Below the 10% mark · Operating profit per dollar of long-term capital
From the company’s SEC filings. The tick on each dial is a common rule-of-thumb level, not a target.
Financial health
Altman Z-Score
-2.96 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
Profitability
Growth (YoY)
Financial Health
Dividends
Annual · latest fiscal year ends 2022-03-31